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Cases of psittacosis are still occurring in birds and in human beings, 
and it  is  obvious that  the  disease  has  become endemic  (1)  in  the 
breeding aviaries of this country and that cases among human beings 
will continue to occur until the breeders close the aviaries or get rid 
of their infected stock.  In view of the fact that laboratory workers 
exposed to infection frequently develop psittacosis it seemed advisable 
to ascertain whether individuals who have had the malady are refrac- 
tory to reinfection and to devise a method for the vaccination of human 
beings against the disease. 
EXPEREKENTAL 
In approaching the problem of vaccination of laboratory workers 
against psittacosis we decided that it would be advisable to ascertain 
what  could  be  accomplished  with  monkeys  before  anything  was 
attempted with human beings.  Consequently, we set out to determine 
(1) whether monkeys that have recovered from psittacosis pneumonia 
are refractory to reinfection, (2) whether such monkeys have neutraliz- 
ing antibodies in their sera,  (3) whether large amounts of psittacosis 
virus  administered to  monkeys intramuscularly  and  intravenously 
produce a serious infection, e.g. psittacosis pneumonia, and (4) whether 
monkeys that have received repeated small doses of active psittacosis 
virus intramuscularly, that is vaccinated monkeys, are refractory to 
intratracheal inoculations of active virus and possess neutralizing anti- 
bodies in their sera. 
Resistance of Monkeys to Reinfection by Psittacosis  Virus 
Previous work (2-4)  has evidenced the fact that parrots, rabbits, 
and mice that have recovered from psittacosis possess a  heightened 
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resistance to reinfection.  It has also been found possible to produce a 
psittacosis pneumonia in monkeys (5) by means of intratracheal injec- 
tions  of  active  virus.  When  the  present  investigation  was  begun, 
however,  there was no definite evidence available regarding the state 
of resistance  of recovered monkeys to  psittacosis  virus.  Before  the 
vaccination of monkeys was undertaken,  it seemed wise to determine 
whether  monkeys  that  have  recovered  from  psittacosis  pneumonia 
are more refractory to  the  virus introduced  intratracheaUy  than are 
normal  control  animals.  The  desired  information  was  obtained  in 
the following manner. 
In each of Monkeys  t 19, 20, and 22 (see Table I), a psittacosis pneumonia was 
produced by means of an intratracheal injection  s of 2 cc. of a 1 per cent emulsion in 
Locke's solution of livers and spleens  from mice infected with psittacosis virus. 
The animals became sick and X-ray pictures of their lungs revealed extensive 
consolidation.  43 days after the infection in Monkeys 19 and 20 and 105 days 
after the infection in Monkey 22, each of Monkeys 19, 20, 22, and 28 (normal con- 
trol animal) received intratracheally 2 cc. of a 1 per cent virus emulsion similar to 
that described above.  Monkey 22 was not sick and X-ray photographs of the 
lungs showed no consolidation.  Monkeys 19 and  20 were not sick,  but X-ray 
pictures showed a  slight involvement of their lungs.  Monkey 28  (the control), 
however, was sick and refused to eat, and X-ray photographs of its lungs revealed 
considerable  pneumonia around  the  hilum  and  at both bases.  Following  the 
X-ray examinations on the 7th day after inoculation the 4 monkeys were sacrificed. 
The  lungs  of  Monkey  22  were essentially  normal macroscopically and  micro- 
scopicagy.  In the gross, the lungs of Monkeys 20 and 19 showed respectively a 
slight amount of pneumonia of both lower lobes and  a  few scattered areas of 
consolidation of the right upper and lower lobes.  Stained  sections of the con- 
sogdated tissues revealed some thickening of the alveolar wags and mononuclear 
elements in the alveolar spaces.  No hemorrhages or areas of necrosis were seen. 
In Monkey 28 (normal control) practically all of the right lower lobe, half of the 
left lower lobe, and approximately a quarter of the right upper lobe were consoli- 
dated.  Stained  sections  of  these  lobes  showed  hemorrhages,  areas  of necrosis, 
thickening of the  alveolar walls,  desquamation of the alveolar epithelium,  and 
mononuclear exudate with fibrin in the alveolar spaces.  The gross  and micro- 
scopic pictures in the lungs of the  control Monkey 28 were decidedly different 
from those found in the lungs of the reinoculated animals, Monkeys 19, 20, and 22. 
The results of the experiment are summarized in Table I. 
1 Approximately half-grown  Macacus  rhesus  monkeys were  used  in  all  ex- 
periments. 
All operations were performed under light ether anesthesia. TABLE  I 
Summary of Experiments Dealing with Immunization of Monkeys  against 
Psittacosis 
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* Serum for this test was obtained 201 days after secondary injection. 
t  Killed and  autopsied. 
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The experiment just described was repeated and similar results were 
obtained.  From these experiments it is obvious that monkeys that 
have  recovered from  psittacosis  pneumonia  are  more  refractory to 
infection  by  the  virus  introduced  intratracheally  than  are  normal 
monkeys.  From our experience it seems that an increased resistance 
to psittacosis is acquired slowly.  Therefore, one should wait at least 
a month after the primary inoculation before testing for a heightened 
resistance in the animals by means of a  secondary injection.  More- 
over,  the  immunity is  only relative,  and  if  too large  an  amount of 
virus is administered in the secondary inoculum one will fail to demon- 
strate a  refractory state. 
Neutralizing  Antibodies  in  the Sera  of Monkeys  Recovered from 
Psittacosis Pneumonia 
In  addition  to  determining  the  presence  of  a  refractory state  in 
monkeys to reinfection by psittacosis virus we attempted to ascertain 
whether the sera of such animals  possess neutralizing antibodies for 
the active agent.  However, when we undertook to demonstrate the 
presence of the antibodies,  it became evident at  once that  a  test in 
which only a few mice and one or two dilutions of virus are employed 
is not adequate.  We then devised the following test which seems to 
give satisfactory results. 
A 20 per cent liver and spleen emulsion from infected mice was prepared and 
centrifuged for 10 minutes at 3000 mP.M.  The supernatant fluid was collected and 
decimal dilutions of it were made with Locke's solution.  These dilutions were not 
allowed to stand for any length of time because the virus dies very rapidly under 
such conditions.  Definite amounts of at least four of the dilutions of virus were 
mixed with equal amounts of the sera being tested.  A positive and a negative 
control serum were run in each experiment.  The mixtures were incubated at 37°C. 
for 2 hours.  Then 5 mice  3 were inoculated intraperitoneally with each mixture, 
each mouse receiving 0.5 cc.  The mice were observed for 18 days.  The percent- 
age of mice that died and the average time of their death were noted.  A summary 
of an experiment is sl~own in Table II. 
An examination of the results shown in Table II reveals that more 
of the mice receiving mixtures of normal serum and virus died than 
did  those  receiving virus  mixed with the  other sera.  Furthermore, 
3 The mice must be from a  relatively uniform stock as regards susceptibility, 
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the average time of death for the former set of mice was shorter than 
that  for the latter.  The  differences in percentages of deaths  and  in 
the  average  times  of  death  are  not  strikingly significant when  con- 
sidered separately, but when  the  two factors are considered together 
TABLE  II 
Summary of an Experiment Illustrating  tke Manner in Which Neutralization  Tests 
Were Performed 
I  I  I  I 
Dilution  of  No. of mice  No. of  Percentage  Average  Neutraliza- 
virus  inoculated  deaths  of deaths  Day of deaths  time  of death  tion index 
Known normal serum -k virus dilutions 
10-4 
10-~ 
10-~ 
10-7 
5  5 
5  5 
5  5 
5  5 
5, 6, 6, 6, 6 
5, 6, 6, 6, 7 
7, 7, 8, 8, 8 
8, 8, 8, 9, 9 
20  20  100  6.9  14.5 
Serum being tested +  virus dilutions 
10 -4  5 
10  -5  4 
10  -6  5 
10  -r  5 
19 
m  T 
6, 7, 7, 8, 8 
6, 7, 8, 9 
8, 8, 8, 12, 12 
10 
79  8.3  9.5 
Known immune serum -]- virus dilutions 
10  -4  5 
10  -6  5 
10  -6  5 
10  -7  4 
19 
5  6, 7, 7, 9, 9 
5  5, 8, 10, 10, 10 
4  9, 10, 12, 12 
1  10 
15  79  8.9  8.9 
Neutralization index =  percentage of deaths divided by average time of death. 
the  results  of  the  experiment  assume  considerable  significance.  In 
order to express both  factors in one figure we have  chosen  as a  neu- 
tralization  index  the  percentage  mortality  divided  by  the  average 
time of death. 
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had recovered  from psittacosis  pneumonia 39 to 187 days previously 
were tested for the presence of neutralizing antibodies and it was found 
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TEXT-FIo. 1.  Graphic portrayal of the results of a neutralization test on speci- 
mens of sera from 1 normal monkey (M. 31) and from 5 monkeys (M. 8, 14, 23, 26, 
29) that had recovered from psittacosis pneumonia, 
that in the majority of the sera such antibodies were present  From 
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Consequently, a month or more was allowed to elapse after infection 
before the sera were drawn for the neutralization tests.  The results 
of one experiment are portrayed in Text-fig. 1 (M. 31 represents the 
results obtained with serum from a normal monkey) and show that M. 
29, M. 8, M. 14, and M. 23 definitely  possessed neutralizing antibodies. 
It is hard to interpret the results obtained with the serum from M. 26. 
Effect of Psittacosis Virus Administered  to Monkeys  Intravenously 
and Intramuscularly 
Before undertaking the vaccination of monkeys with active virus 
we wanted to know whether large amounts of psittacosis virus adminis- 
tered intravenously or intramuscularly would produce a serious infec- 
tion such as a pneumonia.  From previous work (5) we had been led 
to believe that psittacosis virus introduced into monkeys in such a 
manner is relatively harmless.  Nevertheless,  2  experiments, one of 
which will be  described, were performed in order  to obtain definite 
evidence concerning the matter. 
A 1 per cent emulsion of livers and spleens from mice sick of psittacosis was 
made and centrifuged at 3000 R.p.~r. for 5 minutes.  The supernatant fluid  was 
removed and used as an inoculum.  Monkeys  21 and 25 received respectively  2 cc. 
of the inoculum intratracheaUy, while each of Monkeys 17 and 18  received 2 cc. 
of the inoculum mixed with 3 cc. of Locke's solution intravenously and 0.5 cc. 
of the inoculum intramuscularly.  Monkey 25 became very sick and died 5 days 
after the inoculation.  At necropsy an extensive  psittacosis pneumonia was found 
involving all lobes.  Monkey 21 became very sick, had fever, and refused to eat. 
X-ray photographs of the lungs revealed  extensive  pneumonia.  The animal finally 
recovered, however.  Monkeys 17  and  18  were never sick and  had no fever. 
Furthermore, X-ray pictures of their lungs revealed no evidences of pneumonia. 
The results of the experiment described above and of a similar one 
(Monkeys 15, 16, 19, 20) not detailed are shown in Table I and clearly 
indicate that large amounts of active psittacosis virus can be adminis- 
tered intravenously  and intramuscularly to monkeys in relative safety, 
while similar amounts of virus given intratracheally cause extensive 
pneumonia which may be fatal. 
Vaccination of Monkeys against Psittacosis 
At this point we believed that we were ready to proceed with the 
vaccination of monkeys against psittacosis.  To  this  end  6  experi- PERIOD  OF IFII~UN 
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TExT-Fro. 2.  Summary of an experiment in which 3 monkeys were vaccinal 
of virus. 
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psittacosis and then tested for immunity by means of intratracheal inoculations 
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ments were performed in which 14 monkeys (Nos. 1 to 14 in  Table I) 
were  vaccinated  and  then  tested  for  immunity.  Seven  normal 
monkeys  (Nos.  22,  24,  26,  27,  29,  30,  31  in  Table  I)  were  used  as 
controls in the tests.  Inasmuch as all of the experiments were  con- 
ducted in approximately the same manner only one will be  described 
in detail. 
Each of Monkeys 3, 4, and 10 received intramuscularly at weekly intervals 3 
doses (0.1 cc., 0.15 cc., 1.0 cc.) of active psittacosis ~rus contained in a fresh 10 per 
cent emulsion of the livers and spleens of infected mice.  In addition to these in- 
oculations, Monkey 10 received 2 more weekly injections (1.5 co., 2.0 cc.) of similar 
emulsions.  During the period of vaccination the animals showed no signs of illness 
and X-ray photographs of their lungs  taken from time to time revealed no evi- 
dences of pneumonia.  73 days after Monkeys 3 and 4 and 59 days after Monkey 
10 had received their last intramuscular injection of virus, they were tested for 
immunity.  Each of these animals and a normal control (Monkey 24) received 
intratracheally 2 cc. of a  1:100 dilution of a  10 per cent emulsion of livers and 
spleens from mice sick of psittacosis.  The animals  were observed carefully and 
X-ray pictures of all of them were taken on two occasions.  The vaccinated 
monkeys did not become sick  and had no fever; X-ray examinations revealed 
either no evidences or only slight evidences of pneumonia.  The normal control 
monkey became sick, refused to eat, lost weight, became very weak, and had fever; 
X-ray pictures showed extensive pneumonia.  The results of the experiment are 
graphically portrayed in Text-fig. 2 and are summarized in Table I. 
The results of the experiment just described in detail and those of 5 
other  experiments  summarized  in  Table  I  clearly indicate  (1)  that 
repeated intramuscular injections of active psittacosis virus in monkeys 
are relatively harmless and (2) that such injections produce in monkeys 
a  heightened  resistance  to  active psittacosis  virus  introduced intra- 
tracheally. 
Neutralizing  Antibodies in the Sera of Vaccinated Monkeys 
In  addition  to  the  demonstration of the fact that  repeated intra- 
muscular  injections  of  active  psittacosis  virus  lead  to  an  increased 
resistance of monkeys to the  active agent it seemed important  that 
we determine whether such treatment is also followed by the appear- 
ance of neutralizing antibodies in the sera of vaccinated animals.  To 
this end 8 monkeys were bled before the injections of virus were begun 
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before and after immunization were tested at the same time for their 
ability to neutralize psittacosis virus.  Four sets of animals, 2 in each 
group, were handled in this manner, and the results obtained with one 
set will be given in detail. 
Monkeys 13 and 14 were bled and the sera were pooled and placed in the ice box. 
Then the animals received 5 weekly intramuscular  injections of active psittacosis 
virus in the manner described in the preceding section of the paper.  33 days after 
TABLE  III 
Summary of Neutralization  Test Which Shows That Vaccination of Monkeys against 
Psittacosis Leads to the Appearance in Their Sera of Neutralizing  Antibodies 
I  I  Av_,[ 
Dilution of  No. of mice  No. of  Percentage  Neutraliza- 
virus  inoculated  deaths  of deaths  Day of deaths  time  tion index  of death 
Serum before immunization -4-virus dilutions 
I0  -*~  4 
10-6~  4 
10  -6  5 
10  -r  5 
18 
6, 6, 6, 7 
7, 7, 7, 7 
8, 9, 9, 9, 13 
8, 8, I1, 13 
17  94  8.3  11.3 
Serum after immunization -4- virus dilutions 
10  -~  5 
10  -~  5 
10  -t  5 
10  -v  5 
20  50 
7, 8 
9, 10, 10, 11, 11 
9, 13 
13 
I0.1  4.9 
Neutralization index =  percentage of deaths divided by average time of death. 
the last injection the animals were bled again and the sera were pooled and inacti- 
vated at 56°C. for a half an hour.  A neutralization test was made with the sera 
taken before and after immunization.  The results of the experiment are sum- 
marized in Table III and Text-fig. 3. 
The results of the above experiment and of 3 others summarized in 
Table I dearly indicate that repeated intramuscular injections of psit- 
tacosis virus led to the appearance  of neutralizing  antibodies in  the 
sera of the vaccinated monkeys. 222  VACCINATION  AGAINST  PSITTACOSIS 
100 
0 
0 
0 m 
80- 
~0- 
60- 
~0- 
40 
30- 
20- 
I0- 
0  t 
3 
I  • 
t  I  I  I  I  I  t  i  I 
4  3  6  7  8  9  tO  II  12  13  14 
Day~ a~te~  injectio= 
I  I  I  I 
1,5  16  I.'I  18 
TExT-FIG. 3.  Graphic portrayal of the results of a neutralization experiment 
showing that vaccination of monkeys against psittacosis leads to the appearance of 
neutralizing antibodies against the virus in their sera. 
Immunity in Man to Psittacosis 
Before proceeding with the vaccination of man against  psittacosis 
it seemed advisable to look for evidence ill regard to whether an attack 
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the appearance of antibodies in the serum of a  recovered individual. 
In the published reports no instances were found in which psittacosis 
attacked  the  same individual  more than  once.  This  fact, however, 
is not significant, because the attack rate of the disease is so low that 
one might not expect a second attack to occur in the same person even 
though an immune state did not result from the first one.  In regard 
to the presence of antibodies in the sera of human beings convalescent 
from psittacosis Bedson  (6) has shown that weak complement-fixing 
antibodies may be found.  In previous work of ourselves (7)  and of 
Bedson  (6)  few if any neutralizing  antibodies were demonstrated  in 
human  convalescent serum.  With our improved neutralization  test, 
however, we decided to see whether we could obtain different results. 
Neutralization tests were made on sera from 26 individuals.  Many 
of the sera were tested several times and frequently two or more speci- 
mens of serum were obtained from an individual.  Of the 26 people, 
14 gave no history of having had psittacosis, while 12 either had had 
or were suspected of having had the disease 1 month to 31 years pre- 
viously.  Of the  14 individuals with a  negative history,  2 possessed 
and  12 did not possess demonstrable neutralizing  antibodies in  their 
sera.  Of the sera from the 12 people with a positive or questionable 
history of psittacosis, 7 had no demonstrable neutralizing  antibodies, 
1 gave questionable results, and 4 were able to neutralize appreciable 
amounts of virus.  The results of this work which is shown in the sum- 
mary of 16 experiments in Table IV reveal the fact that the neutraliza- 
tion  test is not  a  very reliable one for the diagnosis of psittacosis in 
retrospect.  However,  inasmuch  as  many  of  the  individuals  had 
recovered from the disease several years before the tests vcere made, 
and since it is a  well recognized fact  (8)  that  seasoned bird handlers 
are less likely to contract psittacosis than are novices in the trade, we 
were not discouraged but proceeded with the vaccination  of human 
beings. 
Vaccination of Human Beings against Psittacosis 
In approaching the problem of vaccination of human beings against 
psittacosis we decided that only volunteers would be vaccinated and 
that the first volunteer must be a physician who had not had the dis- 
ease and who had no neutralizing antibodies for the virus in his serum. 224 
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It was further decided that, inasmuch as the period of vaccination is 
5 or 6 weeks, during which time the individual might have a cold, the 
procedure must be safe even under such circumstances.  A  suitable 
volunteer presented himself and we waited until he developed a com- 
mon  cold  accompanied by a  bronchitis before proceeding with the 
vaccination.  As a  control another volunteer, a  physician, who had 
had psittacosis 1½ years previously and who had neutralizing antibodies 
for the virus in his serum was also subjected to vaccination. 
Serum was collected from the volunteers before the inoculations of virus were 
begun.  Then each individual received 6 weekly intramuscular inoculations of 
active psittacosis virus.  The amounts of virus and the order of their administra- 
tion were 0.5 cc. of the following  dilutions of 10 per cent emulsions of livers and 
spleens of infected mice: 1:1000, 1:500, 1:200, 1:100, 1:20, 1:10.  The first and 
last inoculums  contained sufficient  virus to kill 10,000 and 10,000,000 mice respec- 
tively.  1 and 2 weeks after the first injection and 2 and 4 weeks after the last 
inoculation specimens of serum were collected from each individual for neutrali- 
zation tests. 
The intramuscular injections of psittacosis virus into the two volun- 
teers resulted in no considerable ill effects.  The details of the experi- 
ment are shown under Cases 1 and 2 in Text-fig. 4.  The person (Case 
1) who had not had psittacosis previously had two chills accompanied 
by a  fever of short duration after the second inoculation.  The neu- 
tralization indices of the sera taken before, during, and after vaccina- 
tion are recorded in Table IV  (Case  1 of Text-fig. 4  is Individual 7 
of Table IV,  and Case 2 is Individual 2)  and plotted in Text-fig. 4. 
The results of the neutralization tests on specimens of serum collected 
from Case  1 are more fully detailed in Table V  and are graphically 
portrayed in Text-fig. 5.  It is evident from the results of these tests 
that neutralizing antibodies either appeared or increased in amount 
as the result of vaccination. 
While the work was ill progress we had the opportunity to determine 
what effect one injection of a moderate amount of active virus would 
have on an individual who had had psittacosis 3½  years previously 
and who had no neutralizing antibodies in his serum.  Blood was col- 
lected and then 0.5  cc. of a  1:100 dilution of a  10 per cent emulsion 
of livers and spleens from infected mice was given intramuscularly. 
Specimens of blood were again collected 1 and 2 weeks after the inocu- THOMAS  M. RIVERS AND  FRANCIS  F. SCII'VCENTKER  231 
lation.  In Text-fig. 4  (Case 3), Table IV  (Individual  11), and Text- 
fig. 6  the results are shown.  The inoculation led to no more than  a 
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TExT-FIG. 5.  Graphic portrayal of the results obtained in a neutralization test 
on specimens of serum collected from Case 1 before, during, and after vaccination 
against psittacosis. 
slight discomfort in the individual but induced neutralizing antibodies 
to appear rapidly in his serum.  In this instance the response had the 232  VACCINATION  AGAINST  PSITTACOSIS 
TABLE  V 
Summary of a Neutralization Test Which Shows That Vaccination of a Human Being 
(Case 1) agains~ Psittacosis Led to the Appearance of Neutralizing Antibodies 
in His Serum 
Average  Dilution  of  No. of mice  No, of  Percentage  Day of deaths  time  Neutraliza- 
virus  inoculated  deaths  of deaths  of death  tion index 
Serum before immunization +  virus dilutions 
10 -~  5 
10  -e  5 
10  .7  5 
10  -s  5 
20 
7, 7, 7, 7, 9 
8, 8, 8, 9, 9 
9, 9, 12, 12 
11, 12, 13 
L7  85  9.2  9.2 
Serum 1 wk. after 1st injection +  virus dilutions 
10  -5  5 
10  -°  5 
10  -7  5 
10 -s  5 
20 
7, 8, 8, 9, 12 
7, 8, 9, 9, 9 
8, 10, 11, 13 
13, 15 
16  80  9.8  8.2 
Serum 1 wk. after 2nd injection -t- virus dilutions 
10-5 
lO-S 
10-7 
10-s 
6, 7, 7, 8, 9 
8, 8, 9, 9, 9 
8, 9, 9, 13 
9, 15 
9.0  20  [  16  80  8.9 
Serum 2 wks. after 6th injection +  virus dilutions 
10  -~  5 
10  -6  5 
10  -7  5 
10  -8  5 
20 
8, 9, 9, 9, 13 
9, 10, 11, 11 
10, 15 
11  55  10.4  5.3 
Semm4wks. after 6thinjection-bvirus dilutions 
10  -6  5  5 
10  -6  5  3 
10  -7  5  2 
10-~  5  0 
20  10  50 
8, 9, 10, 11, 13 
9, 9, 11 
13, 14 
10.7  4.7 
Neutralization index  =  percentage of deaths divided by average time of death. THOMAS  :E.  RIVERS  AND  FRANCIS  F.  SCHWENTKER  233 
characteristics  of a  secondary rather  than  a  primary reaction  to  an 
antigen.  This finding leads us to believe that  individuals who have 
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TExT-Fro. 6.  Graphic portrayal of the results obtained in a neutralization test 
on specimens of serum collected from Case 3 before and after one intramuscuhr 
injection of psittacosis virus. 
had psittacosis possess an appreciable degree of immunity even though 
they have no demonstrable antibodies in their sera. 
iFour  other  volunteers,  three  laboratory  boys and  one  physician 
(Cases 4, 5, 6, and 7 of Text-fig.  7 which are respectively Individuals 234  VACCINATION  AGAINST  PSITTACOSIS 
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6,  5,  26,  and  25  of  Table  IV),  have  been  vaccinated  in  a  manner 
similar to that described for Cases  1 and 2.  Cases 4  and 5  received 
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TExT-FIG. 8.  Graphic portrayal of the results obtained in a neutralization test 
on specimens of serum collected from Case 4 before, during, and after vaccination 
against psittacosis. 
5 weekly injections of 0.5 cc. of the  following dilutions of 10 per cent 
emulsions of infected livers and spleens:  1 : 1000,  1:500,  1: 100,  1: 20, 
1:10.  For  Cases 6  and  7  the following dilutions  were used:  1:500 THOMAS  M. RIVERS AND  FRANCIS F. SCHWENTKER  237 
1: 500,  1: 100,  1 : 50,  1: 10.  The  individuals  suffered  no  marked ill 
effects from the injections.  In two instances (Cases 4 and 5), however, 
chills and fever similar to those that occasionally occur after typhoid 
vaccination  were  experienced following  the  last  inoculation.  The 
results of the neutralization tests shown in Table IV and Text-figs. 
7  and  8  dearly indicate that neutralizing antibodies  also  appeared 
in the sera of these volunteers as the result of vaccination. 
DISCUSSION 
The results of our work indicate that when psittacosis virus produces 
a pneumonia in man its portal of entry is the upper respiratory tract. 
The  fact is plain  that man is  very unlikely to  contract psittacosis 
pneumonia as the result of the subcutaneous or intramuscular intro- 
duction of active virus.  It is not known whether the individuals who 
have received repeated intramuscular injections of active virus pos- 
sess an increased resistance to psittacosis in addition to the neutraliz- 
ing antibodies in their sera, and, if they do possess such a heightened 
resistance, there is no evidence in regard to the length of time they will 
retain it.  Nevertheless, in view of the results obtained with monkeys, 
one is justified in assuming that a certain degree of protection against 
psittacosis was afforded the human volunteers by means of vaccination. 
Protection of an individual by means of the introduction of an active 
infectious agent through a portal of entry other than the one used in 
nature is an old and established procedure.  For instance, variolation 
was employed for many years as a protective measure against smallpox. 
SUMMARY 
Monkeys that have recovered from psittacosis pneumonia have an 
increased resistance to infection with the virus and possess neutraliz- 
ing antibodies in their sera. 
Large amounts of active psittacosis virus can be introduced intra- 
venously and intramuscularly into monkeys without the production 
of a  serious infection such as pneumonia.  Relatively small amounts 
of  virus  introduced  intratracheally  into  monkeys  usually  lead  to 
psittacosis pneumonia. 
Monkeys vaccinated intramuscularly with unattenuated psittacosis 238  VACCINATION  AGAINST  PSITTACOSIS 
virus  have  an  increased  resistance  to  the  active  agent  and  possess 
neutralizing antibodies in their sera. 
The intramuscular introduction of active psittacosis virus in moder- 
ate  amounts into human beings is relatively harmless,  and repeated 
inoculations lead to  the  appearance  of neutralizing antibodies in the 
sera  of vaccinated individuals. 
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